Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Receivables: 2023-2024

Historic Receivables for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $1.2 million.

  • Upstream Bio's Receivables rose 111.26% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 400.00% up from last year.
  • Per Upstream Bio's latest filing, its Receivables stood at $1.2 million for FY2024, which was up 400.00% from $236,000 recorded in FY2023.
  • Upstream Bio's 5-year Receivables high stood at $1.2 million for FY2024, and its period low was $236,000 during FY2023.
  • Its 2-year average for Receivables is $708,000, with a median of $708,000 in 2023.
  • Data for Upstream Bio's Receivables shows a peak YoY surged of 400.00% (in 2024) over the last 5 years.
  • Upstream Bio's Receivables (Yearly) stood at $236,000 in 2023, then surged by 400.00% to $1.2 million in 2024.